Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,019,544
-$294,415 QoQ
Shares Held
15,985
-3.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#828
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. GILD ranks #5 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,019,544 | 15,985 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,313,959 | 16,603 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,904,310 | 15,515 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,772,226 | 15,966 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $1,422,572 | 12,831 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,321,181 | 11,791 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $608,071 | 6,583 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $557,955 | 6,655 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $474,849 | 6,921 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $504,399 | 6,886 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $623,858 | 7,701 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $599,220 | 7,996 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $571,782 | 7,419 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $596,969 | 7,195 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $613,398 | 7,145 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $427,388 | 6,928 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $430,506 | 6,965 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $440,702 | 7,413 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $538,766 | 7,420 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $542,105 | 7,761 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $556,870 | 8,087 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $485,759 | 7,516 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $381,661 | 6,551 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $327,576 | 5,184 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $447,713 | 5,819 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $407,591 | 5,452 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||